Hansa Biopharma AB appointed Renée Aguiar-Lucander as Chief Executive Officer (CEO), effective immediately. Søren Tulstrup will be stepping down from his position as CEO by mutual agreement after seven years with the company. “On behalf of the Board of Directors, I would like to extend our gratitude to Søren for his leadership and significant contribution to the company during his tenure,” said Peter Nicklin, Chairman of the Board, Hansa Biopharma. “With the appointment of Renée as CEO, Hansa...